Cargando…

Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection

Objective: Hepatitis C virus (HCV) infection has long been treated with interferon therapy (IFN). Currently, more than 90% of IFN-treated patients show a sustained virological response (SVR) when also treated with ribavirin and/or a protease inhibitor. Histological inflammation and fibrosis improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nirei, Kazushige, Kanda, Tatsuo, Nakamura, Hitomi, Matsuoka, Shunichi, Takayama, Tadatoshi, Sugitani, Masahiko, Moriyama, Mitsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859769/ https://www.ncbi.nlm.nih.gov/pubmed/29559835 http://dx.doi.org/10.7150/ijms.23147

Ejemplares similares

Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection
por: Nirei, Kazushige, et al.
Publicado: (2017)

Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients
por: Nirei, Kazushige, et al.
Publicado: (2021)

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils
por: Matsuoka, Shunichi, et al.
Publicado: (2018)

The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma
por: Moriyama, Mitsuhiko, et al.
Publicado: (2022)

Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients
por: Nirei, Kazushige, et al.
Publicado: (2017)

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
por: Sasaki, Reina, et al.
Publicado: (2018)

Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma
por: Midorikawa, Yutaka, et al.
Publicado: (2019)

Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis
por: Ohnishi, Masahiko, et al.
Publicado: (2017)

Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients
por: Mizutani, Taku, et al.
Publicado: (2022)

The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma
por: Ogawa, Masahiro, et al.
Publicado: (2023)

Expression of Intercellular Adhesion Molecule-1 in the Livers of Rats Treated with Diethylnitrosamine
por: Matsuoka, Shunichi, et al.
Publicado: (2009)

Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease
por: Ogawa, Masahiro, et al.
Publicado: (2019)

Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir
por: Totsuka, Mai, et al.
Publicado: (2021)

Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan
por: Yamana, Yoichiro, et al.
Publicado: (2021)

Apoptosis and non-alcoholic fatty liver diseases
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Association of mRNA expression of iron metabolism-associated genes and progression of non-alcoholic steatohepatitis in rats
por: Higuchi, Teruhisa, et al.
Publicado: (2018)

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
por: Masuzaki, Ryota, et al.
Publicado: (2022)

Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Exosomes and Hepatocellular Carcinoma: From Bench to Bedside
por: Sasaki, Reina, et al.
Publicado: (2019)

A prediction model for the grade of liver fibrosis using magnetic resonance elastography
por: Mitsuka, Yusuke, et al.
Publicado: (2017)

Zinc Supplementation Improves the Outcome of Chronic Hepatitis C and Liver Cirrhosis
por: Matsuoka, Shunichi, et al.
Publicado: (2009)

Characteristics of Hepatic Schwannoma Presenting as an Unusual Multi-cystic Mass on Gadoxetic Acid Disodium-enhanced MR Imaging
por: Haradome, Hiroki, et al.
Publicado: (2017)

Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C
por: Matsumura, Hiroshi, et al.
Publicado: (2012)

Rapid Recovery from Acute Liver Failure Secondary to Pancreatoduodenectomy-Related Non-Alcoholic Steatohepatitis
por: Nirei, Kazushige, et al.
Publicado: (2013)

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
por: Hamdane, Nourdine, et al.
Publicado: (2019)

Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin
por: Kurokawa, Tomoharu, et al.
Publicado: (2016)

Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis
por: Gragnani, Laura, et al.
Publicado: (2021)

Hepatocellular Carcinoma with Sarcomatoid Change without Anticancer Therapies
por: Yoshida, Naoki, et al.
Publicado: (2013)

Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
por: Masuzaki, Ryota, et al.
Publicado: (2020)

Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin
por: Kanda, Tatsuo, et al.
Publicado: (2016)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality
por: Wang, Yijin, et al.
Publicado: (2019)

Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
por: Sasaki, Reina, et al.
Publicado: (2020)

Focal Sinusoidal Obstruction Syndrome Caused by Oxaliplatin-Induced Chemotherapy: A Case Report
por: Kawai, Takaharu, et al.
Publicado: (2016)

Next-generation des-r-carboxy prothrombin for immunohistochemical assessment of vascular invasion by hepatocellular carcinoma
por: Yamazaki, Shintaro, et al.
Publicado: (2020)

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
por: Smit, Colette, et al.
Publicado: (2015)

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis
por: Radhakrishnan, Kavita, et al.
Publicado: (2019)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

Involvement of proliferation of atypical hepatocytes and CDT 1 in the liver cancer of rats administered the diethylnitrosamine
por: Ogawa, Masahiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_snbsl0o4dmubu7a71dfj1gh748